BOOST: Gynecology—Integrated Science and Practice (ISP) Session

Abstract Archives of the RSNA, 2009

RO35

BOOST: Gynecology—Integrated Science and Practice (ISP) Session

Multisession Courses — Genitourinary Radiology, Obstetric/Gynecologic Radiology, Radiation Oncology, Oncologic Imaging,

Presented on December 1, 2009

Participants

Nina A. Mayr MD, Presenter: Nothing to Disclose

William Small MD, Presenter: Research grant, Genentech, Inc

LEARNING OBJECTIVES

1) The speakers will provide a perspective of current innovations, challenges and controversies in radiation therapy for gynecologic cancer with reference to the abstract presentations in the session. 2) Following this session the participant should gain an understanding of new research results and therapeutic approaches relevant to the practice of radiation therapy and multi-modality management in gynecologic cancer.

ABSTRACT

Sub-Events

RO35-01	Invited Speaker: The Use of Surrogate Markers for Treatment Outcomes in Gynecological Malignancies&#8212Ready for Prime Time? William Small MD
RO35-03	Prognostic Significance of 3 Tesla Magnetic Resonance Spectroscopy in Patients with Uterine Cervical Cancer Undergoing Radiotherapy: Initial Experience Mayumi Takeuchi MD \| Kenji Matsuzaki MD, PhD \| Hiromu Nishitani MD, PhD \| Akiko Kubo MD \| Takashi Kawanaka MD \| Shunsuke Furutani \| Kyosuke Osaki MD \| Hitoshi Ikushima MD
RO35-04	Use of Bladder Dose as a Surrogate for Small Bowel Toxicity in Radical Brachytherapy for Cervical Cancer Ciara Lyons MBBCh \| Geraldine Workman \| Monica O'Toole \| Katherine Robinson \| Jackie Clarke
RO35-05	Comparative Dosimetric Analysis of Intensity Modulated Whole Pelvic Radiation Therapy with 3-D Conformal Radiation Therapy for Cervical Cancer Maura Campitelli MD \| Anne De La Rochefordiere \| Chantal Dauphinot \| Alexia Savignoni \| Corine Plancher \| Pascal Francois \| Severine Alran \| Virginie Fourchotte \| Vincent Servois MD \| Paul Cottu
RO35-06	The Comparison of Radiological Response versus Biochemical Response in Ovarian Cancer Patients Receiving Chemotherapy during Phase II Trials Mizuki Nishino MD \| Gordon Harris PhD \| Nikhil Ramaiya MD \| Jyothipriya Jagannathan MBBS \| Annick Van Den Abbeele MD \| William Hanlon \| Xiaozhou Ma MD \| Mengye Guo \| Jeffrey Yap PhD \| 00030490-DMT et al
RO35-07	Tumor Heterogeneity and Outcome Prediction: Sampling Poorly Perfused Tumor Pixels Michael Knopp MD, PhD \| William Yuh MD, MSEE \| Simon Lo MD \| Nina Mayr MD \| Steffen Sammet MD, PhD \| Jun Zhang MD \| Jian Wang PhD \| Hualin Zhang PhD \| 00030490-DMT et al
RO35-08	Prediction of Prognosis of Advanced Cervical Cancers after Radiotherapy by Real-time PCR Yoko Harima MD, PhD \| Koshi Ikeda MD, PhD \| Keita Utsunomiya MD, PhD \| Atsushi Komemushi MD, PhD \| Minoru Kamata MD, PhD \| Satoshi Sawada MD, PhD
RO35-09	Preservation of Ovarian Function Following Oophoropexy with Subsequent Ovarian Shielding during Pelvic Irradiation for the Treatment of Gynecologic Cancer Luqman Dad MD

Cite This Abstract

Mayr, N, Small, W, BOOST: Gynecology—Integrated Science and Practice (ISP) Session. Radiological Society of North America 2009 Scientific Assembly and Annual Meeting, November 29 - December 4, 2009 ,Chicago IL. http://archive.rsna.org/2009/8000765.html